Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor.

ABSTRACT:

SUBMITTER: Shi ZY 

PROVIDER: S-EPMC11136694 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature